Literature DB >> 18065223

The need for advanced breast cancer treatment guidelines: results of an internet-based survey.

Andrew Wardley1.   

Abstract

Although not curable, advanced breast cancer is treatable, however, treatment options are many and varied, and unlike early breast cancer (EBC), consistent guidelines are lacking. Breast cancer physicians were surveyed to assess the emotional impact of recurrence, factors affecting their treatment decisions, the role of guidelines in the management of advanced breast cancer and the need for new guidelines. Overall, distress levels were higher at recurrence than at first diagnosis of early breast cancer for both patients and physicians and the goal of treatment for this disease stage was to improve the patient's quality of life, delay disease progression and improve overall survival. While most respondents (96%) use the currently available guidelines, improvements are required, including the development of uniform global guidelines and recommendations for specific patient groups. Interactive computer programs and e-mail updates should also be utilised to ensure physicians are able to make fully informed decisions regarding optimum treatment.

Entities:  

Mesh:

Year:  2007        PMID: 18065223     DOI: 10.1016/j.breast.2007.10.014

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  1 in total

1.  In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer.

Authors:  Anne E Lykkesfeldt; Katrine L Henriksen; Birgitte B Rasmussen; Hironobu Sasano; Dean B Evans; Susanne Møller; Bent Ejlertsen; Henning T Mouridsen
Journal:  BMC Cancer       Date:  2009-06-16       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.